| Literature DB >> 24885645 |
Erika Geraldina Spaich1, Niels Svaneborg, Helle Rovsing Møller Jørgensen, Ole Kæseler Andersen.
Abstract
BACKGROUND: Gait deficits are very common after stroke and improved therapeutic interventions are needed. The objective of this study was therefore to investigate the therapeutic use of the nociceptive withdrawal reflex to support gait training in the subacute post-stroke phase.Entities:
Mesh:
Year: 2014 PMID: 24885645 PMCID: PMC4026111 DOI: 10.1186/1743-0003-11-81
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Demographics of the subjects
| 1 | 60 | 28 | Ischemic infarct – basal ganglia | left | NWR-FET | 1 | 18.6 | 47.3 |
| 2 | 77 | 17 | Ischemic infarct – corona radiata | right | Control | 1 | 18.7 | |
| 3 | 76 | 32 | Bilateral small ischemic infarcts in cerebrum - Ischemic infarct pons | left | NWR-FET | 0 | 17.0 | 24.1 |
| 4 | 45 | 16 | Ischemic infarct – area of middle cerebral artery | right | NWR-FET | 0 | 18.3 | 18.6 |
| 5 | 50 | 31 | Hemorrhage – intracerebral | right | Control | 2 | 16.7 | |
| 6 | 62 | 34 | Ischemic infarct – lentiform nucleus and lateral to the left lateral ventricle | right | Control | 1 | 18.7 | |
| 7 | 70 | 62 | Ischemic infarct – parieto-occipital lobe | left | NWR-FET | 0 | 15.6 | 27.5 |
| 8 | 70 | 15 | Ischemic infarct – lentiform nucleus and lateral to the left lateral ventricle | right | Control | 2 | 18.1 | |
| 9 | 76 | 21 | Ischemic infarct – area of middle cerebral artery | left | NWR-FET | 2 | 17.5 | 9.3 |
| 10 | 71 | 13 | Ischemic infarct – lentiform nucleus | left | Control | 1 | 17.1 | |
| 11 | 77 | 19 | Ischemic infarct – parietal lobe | right | NWR-FET | 2 | 17.0 | 10.2 |
| 12 | 56 | 17 | Ischemic infarct – corona radiata, temporal lobe and basal ganglia | left | Control | 1 | 17.8 | |
| 13 | 77 | 33 | Hemorrhage – intracerebral | left | NWR-FET | 1 | 17.9 | 16.6 |
| 14 | 82 | 18 | Ischemic infarct – area of middle cerebral artery | left | NWR-FET | 1 | 16.2 | 12.4 |
| 15 | 62 | 14 | Hemorrhage – basal ganglia | left | NWR-FET | 1 | 17.6 | 13.1 |
| 16 | 83 | 23 | Ischemic infarct – semioval center | right | Control | 2 | 16.2 | |
| 17 | 68 | 29 | Ischemic infarct – internal capsule | left | Control | 1 | 16.5 | |
| 18 | 60 | 44 | Hemorrhage – intracerebral | right | NWR-FET | 0 | 16.8 | 33.3 |
| 19 | 75 | 62 | Idiopathic CVA | right | Control | 0 | 16.4 | |
| 20 | 39 | 62 | Hemorrhage – intracerebral | right | NWR-FET | 0 | 16.1 | 26.3 |
| 21 | 75 | 25 | Ischemic infarct – external capsule | right | NWR-FET | 2 | 16.6 | 22.9 |
| 22 | 57 | 40 | Hemorrhage – thalamus | right | NWR-FET | 2 | 15.9 | 14.6 |
| 23 | 75 | 23 | Ischemic infarct – area of middle cerebral artery | right | NWR-FET | 1 | 16.2 | 21.7 |
| 24 | 51 | 56 | Ischemic infarct – area of middle cerebral artery | right | Control | 0 | 15.5 | |
| 25 | 78 | 44 | Ischemic infarct – insula, lentiform nucleus and caudal nucleus | right | Control | 0 | 16.1 | |
| 26 | 58 | 36 | Hemorrhage – intracerebral | left | Control | 2 | 16.6 | |
| 27 | 79 | 20 | Hemorrhage – external capsule | right | NWR-FET | 2 | 16.8 | 20.0 |
| 28 | 66 | 16 | Bilateral ischemic infarcts – cerebellum and brain stem | left | Control | 0 | 17.9 | |
| 29 | 36 | 19 | Ischemic infarct – area of middle cerebral artery | left | Control | 0 | 17.3 | |
| 30 | 80 | 39 | Ischemic infarct – pre- and post-central gyrus (left) parietal lobe (right) | right | Control | 2 | 16.2 |
The patients are numbered chronologically according to the date of inclusion in the study. The stimulation intensity corresponds to the average across 20 training sessions for the NWR-FET group. The mean training time corresponds to the average amount of minutes effectively used for training, excluding pauses, during the 20 training sessions. CVA: cerebrovascular accident.
Functional Ambulation Category test scores at the different evaluation sessions
| NWR-FET | 1 [0; 2] | 2 [2; 3] | 4 [2; 5] | 4.5 [2; 5] |
| Control | 1 [0; 2] | 2 [1; 2] | 2 [2; 3] | 4 [2; 5] |
Data are presented as median and 25th and 75th percentiles in brackets.
Figure 1Walking velocity. Preferred and fast walking velocities at inclusion (evaluation 1), immediately after completion of training (evaluation 2), 1 month (evaluation 3), and 6 months (evaluation 4) after completion of training. Asterisk indicates a statistically significant difference between groups after finishing treatment (p < 0.001).
Figure 2Gait cycle and Stance phase. Duration of the Gait cycle and of the Stance phase in the hemiparetic side stratified according to the FAC-test score at inclusion time (n = 5 for the NWR-FET and control groups for each FAC group). Values are normalized per subject to the mean at inclusion time to correct for differences at inclusion and shown at inclusion (evaluation 1), immediately after completion of training (evaluation 2), 1 month (evaluation 3), and 6 months (evaluation 4) after completion of training. Mean values at inclusion time are shown in Table 3. Asterisk indicates a statistically significant difference between groups after finishing treatment (p < 0.002). Square indicates a statistically significant interaction between group and evaluation session (p < 0.001).
Duration of gait cycle and stance phase in the hemiparetic side at inclusion time
| Gait cycle [s] | | | |
| NWR-FET | 2.59 ± 0.08* | 1.95 ± 0.03* | 1.81 ± 0.03* |
| Control | 3.25 ± 0.10 | 2.32 ± 0.03 | 2.51 ± 0.03 |
| Stance phase (hemiparetic side) [% of gait cycle] | | | |
| NWR-FET | 0.56 ± 0.01 | 0.61 ± 0.01 | 0.69 ± 0.01* |
| Control | 0.51 ± 0.01 | 0.58 ± 0.01 | 0.60 ± 0.01 |
Data are presented as average across subjects ± SEM and stratified by FAC score at inclusion time. Asterisk indicates a statistically significant difference between groups (NWR-FET and Control) (p < 0.001).
Figure 3Stance time Symmetry Ratio. Symmetry Ratio at inclusion (evaluation 1), immediately after completion of training (evaluation 2), 1 month (evaluation 3), and 6 months (evaluation 4) after completion of training. The Symmetry Ratio was calculated as the ratio between the duration of the stance time in the paretic limb and the stance time in the contralateral limb, provided that the larger of the two values is used in the numerator. The stippled horizontal line represents the normative cut point of 1.05. Asterisk indicates a statistically significant difference between groups after finishing treatment (p < 0.02).